Vedolizumab
This biologic medication is given by intravenous infusion to treat moderate to severe Crohn's disease and ulcerative colitis in adults who have not responded to other treatments. It works by blocking a molecule called alpha4-beta7 integrin, which prevents inflammatory immune cells from entering the intestinal tissue. Because it acts selectively on the gut, it has a lower risk of systemic immune suppression compared to some other biologics.
Terapötik Alanlar
Pharmacokinetics (PK)
Pharmacodynamics (PD)
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Sıkça Sorulan Sorular
This biologic medication is given by intravenous infusion to treat moderate to severe Crohn's disease and ulcerative colitis in adults who have not responded to other treatments. It works by blocking a molecule called alpha4-beta7 integrin, which prevents inflammatory immune cells from entering the intestinal tissue. Because it acts selectively on the gut, it has a lower risk of systemic immune suppression compared to some other biologics.
Yes, Vedolizumab is an approved drug. It has reached clinical phase 4. It is classified as a Antibody.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1743087. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="vedolizumab"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/vedolizumab/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/vedolizumab/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/vedolizumab/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="vedolizumab"></drugfyi-drug>